Dietary Supplements and Autism Ranking:

Other Reading

This section provides a select list of publications on the topic of dietary supplements. For more publications on this topic please see our publications database.

If you know of any other publications we should list on this page please email info@informationautism.org

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.

Related Other Reading

• Adams J. B., McGinnis W. (2001) Vitamins, minerals and autism. Advocate. 34(4),
  
  
• Adams J. B. (2007) Summary of biomedical treatments for autism. San Diego: CA: Autism Research Institute
  
  
• Alanazi A. S. (2013) The role of nutraceuticals in the management of autism. Saudi Pharmaceutical Journal. 21(3), Read Abstract (New Window)
  
  
• Amminger G. et al. (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biological Psychiatry. 61(4), Read Abstract (New Window)
  
  
• Autism Research Institute (2008) Di-methyl-glycine (DMG). San Diego: CA: Autism Research Institute
  
  
• Bazian (2011) Supplements: Who needs them. A Behind the Headlines report. London: Bazian Read Full (New Window)
  
  
• British Dietetic Association (2016) Vitamin D. London: Read Full (New Window)
  
  
• Food Standards Agency (2003) Safe upper levels for vitamins and minerals. London: Food Standards Agency Read Full (New Window)
  
  
• Food Standards Agency (2000) Vitamins and minerals. London: Food Standards Agency Read Full (New Window)
  
  
• Kałużna-Czaplińska J., Błaszczyk S. (2012) The level of arabinitol in autistic children after probiotic therapy. Nutrition. 28(2), Read Abstract (New Window)
  
  
• Kawicka A., Regulska-Ilow B. (2013) How nutritional status, diet and dietary supplements can affect autism. A review. Roczniki Panstwowego Zakladu Higieny. 64(1), Read Abstract (New Window) Read Full (New Window)
  
  
• Martí L. F. (2014) Dietary interventions in children with autism spectrum disorders: An updated review of the research evidence. Current Clincial Pharmacology. 9(4), Read Abstract (New Window)
  
  
• McCracken J. T. (2005) Safety issues with drug therapies for autism spectrum disorders. Journal of Clinical Psychiatry. 66 Read Abstract (New Window)
  
  
• National Institute for Health and Clinical Excellence (2012) Autism in adults: diagnosis and management. London: National Institute for Health and Clinical Excellence Read Full (New Window)
  
  
• National Institute for Health and Clinical Excellence (2013) Autism spectrum disorder in under 19s: support and management. London: National Institute for Health and Clinical Excellence Read Full (New Window)
  
  
• Nye C., Brice A. (2005) Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database of Systematic Reviews. 44 Read Abstract (New Window) Read Full (New Window)
  
  
• Office of Dietary Supplements (2018) Vitamin B6. Bethesda, MD: Office of Dietary Supplements Read Full (New Window)
  
  
• Office of Dietary Supplements (2006) Dietary supplement fact sheet: Vitamin B12. Bethesda, MD: Office of Dietary Supplements Read Full (New Window)
  
  
• Office of Dietary Supplements (2006) Dietary supplements: Background information. Bethesda, MD: Office of Dietary Supplements Read Full (New Window)
  
  
• Page T. (2000) Metabolic approaches to the treatment of autism spectrum disorders. Journal of Autism and Developmental Disorders. 30(5), Read Abstract (New Window)
  
  
• Stewart P. A. et al. (2015) Dietary supplementation in children with autism spectrum disorders: Common, insufficient, and excessive. Journal of the Academy of Nutrition and Dietetics. Read Abstract (New Window)
  
  
• Tsai H. et al. (2012) Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice. 66(11), Read Abstract (New Window)
  
  
• Wake R. et al. (2013) Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study. Journal of Child and Adolescent Psychopharmacology. 23(5), Read Abstract (New Window)
  
  

---

Updated

16 Jun 2022

Last Review

01 Apr 2017

Next Review

01 Aug 2023